Media center
Press release
Owkin Launches K Navigator, a Ground-breaking Agentic Co-pilot to Speed up Breakthroughs in Biomedical Research by 20x
Built by biologists, for biologists. Free to use for academic researchers.
May 6, 2025
Press release
Owkin Launches K Navigator, a Ground-breaking Agentic Co-pilot to Speed up Breakthroughs in Biomedical Research by 20x
Built by biologists, for biologists. Free to use for academic researchers.
May 6, 2025
Explore
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Press release
How Owkin trains AI models without transferring data with federated learning
October 15, 2021
How Owkin trains AI models without transferring data with federated learning
October 15, 2021
Press release
Owkin named MedTech Visionaries: best oncology AI company for precision medicine
October 15, 2021
Owkin named MedTech Visionaries: best oncology AI company for precision medicine
October 15, 2021
In the media
Owkin is opening a new office in Basel, Switzerland
October 15, 2021
Owkin is opening a new office in Basel, Switzerland
October 15, 2021
Basel Area
In the media
Gustave Roussy and Owkin use AI to predict the relapse risk of breast cancer patients
October 15, 2021
Gustave Roussy and Owkin use AI to predict the relapse risk of breast cancer patients
October 15, 2021
Pharmacy Time
In the media
Owkin’s breast cancer research is featured on TF1
October 10, 2021
Owkin’s breast cancer research is featured on TF1
October 10, 2021
My TFI
In the media
MELLODDY releases its second year results: Improved model performance using federated learning in drug discovery
September 27, 2021
MELLODDY releases its second year results: Improved model performance using federated learning in drug discovery
September 27, 2021
MELLODY
In the media
Owkin's deep learning model applied to digital pathology slides to predict the relapse risk in invasive breast cancer
September 19, 2021
Owkin's deep learning model applied to digital pathology slides to predict the relapse risk in invasive breast cancer
September 19, 2021
ESMO
Press release
Owkin to develop innovative methods for enhancing AI external control arms
September 15, 2021
Owkin to develop innovative methods for enhancing AI external control arms
September 15, 2021
Press release
Owkin and Cleveland Clinic develop an artificial intelligence model to predict liver cancer prognosis
September 15, 2021
Owkin and Cleveland Clinic develop an artificial intelligence model to predict liver cancer prognosis
September 15, 2021
Press release
AI predicts recurrence risk for women with common breast cancer
September 15, 2021
AI predicts recurrence risk for women with common breast cancer
September 15, 2021